NCT00282542|Withdrawn
Hepatocyte Transplantation as a Life Support Bridge
The Use of Human Hepatocyte Transplantation as a Life Support Bridge in Terminal Liver Failure
Loading search results
The Use of Human Hepatocyte Transplantation as a Life Support Bridge in Terminal Liver Failure
Sponsor study identifier
interventional
0
0 countries
N/A
Study Start
May 2000
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
January 2006
Date type not reportedThis date has not been verified as actual or estimated.
The purpose of this study is to gain knowledge about the result of infusing liver cells, carefully matched to blood type, into a subject's body. The hope is that this procedure will aid functions of the liver and prevent death, enable a transplant procedure to be carried out if a donated liver becomes available, and lessen complications in postoperative recovery. There is no guarantee that any of these benefits will be re eived, but even if they are not, the hope is that knowledge gained by using this procedure will be of future benefit to others who also suffer from liver disease.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2006
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 2000
Date type not reportedThis date has not been verified as actual or estimated.
January 2006
Date type not reportedThis date has not been verified as actual or estimated.
January 20, 2006
Actual (reported)January 26, 2006
Actual (reported)Survival to liver transplantation
Liver Function Normalization
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Robert A Fisher, MD, FACS
VCU Health System
0 participants (actual enrollment reported by the registry).
First Submitted
January 20, 2006
First Posted
January 26, 2006
Study Start
May 2000
Date type not reportedThis date has not been verified as actual or estimated.
Patients' Outcome With Severe or Fulminant Hepatic Insufficiency, Hospitalized in the Public Hospitals of Paris
Study Completion
January 2006
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
January 31, 2017
Record last verified: 2017-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: